Physicians Launch National Registry to Evaluate Sprix for Pain Management

A group of academic emergency medicine specialists has launched a national registry to gather patient feedback on Sprix nasal spray for pain management, Regency Therapeutics announced today.

The purpose of the registry, led by Charles Pollack, MD, of the University of Pennsylvania Health System, is to evaluate patients' experience using the nasal spray to alleviate pain associated with medical problems that cause them to seek emergency care. The study will compare patient feedback on the effectiveness and safety of Sprix to that of patients prescribed oral narcotics.

"Moderate to moderately severe pain is one of the most common reasons patients seek care in emergency departments, but emergency department clinicians often do not provide adequate treatment of pain because of ingrained prescribing habits and concerns about the appropriate use of narcotic analgesics," said Dr. Pollack. "One of the goals of our study is to understand the overall impact of acute pain and its different treatments on patients after they leave the emergency department, including patient satisfaction, quality of life, and back-to-work/normal activities outcomes."

Related Articles on Pain Management:

Study: More Patients Using Cannabinoids for Fibromyalgia Pain
10 Pain Management Specialist Appointments
FDA Approves Lyrica for Neuropathic Pain Management

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast